Efficacy and Safety of Etanercept in Psoriasis after Switching from Other Treatments
作者： Annamaria Mazzotta , Maria Esposito , Antonio Costanzo , Sergio Chimenti
DOI: 10.2165/11310770-000000000-00000
关键词:
摘要: Background: Since targeted biologic treatments have been introduced for the treatment of plaque-type psoriasis and psoriatic arthritis, switching between different medications has become necessary in selected patients, particularly after failures.
springer.com
sci-hub.se 参考文章(16)
Sentinel node biopsy in the management of primary cutaneous melanoma. British Journal of Dermatology. ,vol. 152, pp. 176- 176 ,(2005) , 10.1111/J.1365-2133.2005.06407.X
Pascal Claudepierre, Valérie Farrenq, Xavier Chevalier, André Marini-Portugal, Jean-David Cohen, Caroline Delaunay, Infliximab to etanercept switch in patients with spondyloarthropathies and psoriatic arthritis: preliminary data. The Journal of Rheumatology. ,vol. 32, pp. 2183- 2185 ,(2005)
Safety and efficacy study on etanercept in patients with plaque psoriasis. British Journal of Dermatology. ,vol. 152, pp. 187- 189 ,(2005) , 10.1111/J.1365-2133.2005.06306.X
Menno A. de Rie, Amber Y. Goedkoop, Jan D. Bos, Overview of psoriasis Dermatologic Therapy. ,vol. 17, pp. 341- 349 ,(2004) , 10.1111/J.1396-0296.2004.04037.X
Gerard Pitarch, José Luís Sánchez-Carazo, Laura Mahiques, Vicente Oliver, Efficacy of Etanercept in Psoriatic Patients Previously Treated with Infliximab Dermatology. ,vol. 216, pp. 312- 316 ,(2008) , 10.1159/000113943
T. Fredriksson, U. Pettersson, Severe psoriasis--oral therapy with a new retinoid. Dermatology. ,vol. 157, pp. 238- 244 ,(1978) , 10.1159/000250839
Satomi Terajima, M. Higaki, Yasuko Igarashi, Toshitatsu Nogita, Makoto Kawashima, An important role of tumor necrosis factor-alpha in the induction of adhesion molecules in psoriasis. Archives of Dermatological Research. ,vol. 290, pp. 246- 252 ,(1998) , 10.1007/S004030050299
Craig L. Leonardi, Jerold L. Powers, Robert T. Matheson, Bernard S. Goffe, Ralph Zitnik, Andrea Wang, Alice B. Gottlieb, Etanercept as Monotherapy in Patients with Psoriasis New England Journal of Medicine. ,vol. 349, pp. 2014- 2022 ,(2003) , 10.1056/NEJMOA030409
R Van Vollenhoven, A Harju, S Brannemark, L Klareskog, Treatment with infliximab (Remicade) when etanercept (Enbrel) has failed or vice versa: data from the STURE registry showing that switching tumour necrosis factor α blockers can make sense Annals of the Rheumatic Diseases. ,vol. 62, pp. 1195- 1198 ,(2003) , 10.1136/ARD.2003.009589
C.H. Smith, A.V. Anstey, J.N.W.N. Barker, A.D. Burden, R.J.G. Chalmers, D. Chandler, A.Y. Finlay, C.E.M. Grifitths, K. Jackson, N.J. McHugh, K.E. McKenna, N.J. Reynolds, A.D. Ormerod, , British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005. British Journal of Dermatology. ,vol. 153, pp. 486- 497 ,(2005) , 10.1111/J.1365-2133.2005.06893.X